Items where Author is "Kaiser, C."

Yes

Kaiser, C. and Eckhout, E. and Jäger, K. A.. (2009) 8. ACCP Guidelines on Antithrombotic Therapy. Schweizerisches Medizin-Forum, Vol. 9. pp. 30-31.

Jeger, R. V. and Schneiter, S. and Kaiser, C. and Bonetti, P. O. and Brunner-La Rocca, H. and Handke, M. and Osswald, S. and Buser, P. T. and Pfisterer, M. E. and Basket, Investigators. (2009) Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Cardiology, 112 (1). pp. 49-55.

Pfisterer, M. and Brunner-La Rocca, H. P. and Rickenbacher, P. and Hunziker, P. and Mueller, C. and Nietlispach, F. and Leibundgut, G. and Bader, F. and Kaiser, C. and Basket, . (2009) Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice : does stent diameter matter? Three-year follow-up of BASKET. European Heart Journal, Vol. 30. pp. 16-24.

Pfisterer, M. and Bertel, O. and Bonetti, P. O. and Brunner-La Rocca, H. P. and Eberli, F. R. and Erne, P. and Galatius, S. and Hornig, B. and Kiowski, W. and Pachinger, O. and Pedrazzini, G. and Rickli, H. and De Servi, S. and Kaiser, C. and Basket-Prove, Investigators. (2008) Drug-eluting or bare-metal stents for large coronary vessel stenting? : the BASKET-PROVE (PROspective Validation Examination) trial : study protocol and design. American heart journal, Vol. 155. pp. 609-614.

Pfisterer, M. and Brunner-La Rocca, H. P. and Kaiser, C.. (2008) The balance of risks and benefits of drug-eluting versus bare-metal stents. Journal of the American College of Cardiology, Vol. 51, H. 9 , S. 972 ; author reply 972-973.